About ObsEva
ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.
|
|
|
11-50 employees
View all ObsEva employees
|
|
IT Services and IT Consulting
|
|
Geneva
|
|
Nove
|
ObsEva Alternatives
Frequently Asked Questions about ObsEva
Ernest Loumaye is the CEO of ObsEva. To contact Ernest Loumaye email at [email protected].
The decision makers in ObsEva are Angela Piazzi, Michel Brethous, Ernest Loumaye, etc. Click to Find ObsEva decision makers emails.
ObsEva Staff Directory
Search ObsEva Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
